Correlation analysis of epicardial adipose tissue thickness, C-reactive protein, interleukin-6, visfatin, juxtaposed with another zinc finger protein 1, and type 2 diabetic macroangiopathy

Table 1 Demographic characteristics

	Complications Group (n = 82)	Diabetes Group (n = 85)	Healthy Control Group(n = 90)	χ²/t	P value
Gender (male/female)	43/39	45/40	47/43	0.009	0.996
Age (years)	55.4 ± 5.2	55.9 ± 6.2	56.1 ± 6.2	0.355	0.702
WHR	1.03 ± 0.03^a,b	0.95 ± 0.05	0.91 ± 0.06	133.612	<0.001
BMI (kg/m²)	25.02 ± 2.28	24.79 ± 2.12	24.02 ± 2.39	0.331	0.719
Duration of diabetes (years)	4.03 ± 0.38	3.97 ± 0.41	–	0.981	0.328
Medications for diabetes and dyslipidemia				1.428	0.629
Insulin	33 (37.80)	33 (38.82)
Dimethyldiguanide	29 (35.37)	27 (31.76)
Alpha-glucosidase inhibitor	15 (18.29)	28 (32.94)
Statins	20 (24.39)	28 (32.94)

^acompare with Diabetes Group (P<0.05); ^bcompare with Healthy Control Group (P<0.05); WHR waist hip ratio, BMI body mass index

ISSN: 1476-511X